The Food and Drug Administration has approved a software product from an artificial intelligence startup that is aimed at making it easier for doctors and other medical professionals to take ultrasound pictures of the heart, also known as echocardiograms.
The technology, developed by San Francisco-based Caption Health, could help more hospitals use the diagnostic test, which currently requires expertise that is in short supply.
“Today’s marketing authorization enables medical professionals who may not be experts in ultrasonography, such as a registered nurse in a family care clinic or others, to use this tool,” said Robert Ochs, deputy director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health. “This is especially important because it demonstrates the potential for artificial intelligence and machine learning technologies to increase access to safe and effective cardiac diagnostics that can be life-saving for patients.”
About the Author Reprints
Me parece muy bien todas las ayudas externas que se puedan aplicar para hacer un diagnostico mas rápido y mas efectivo para los pacientes;de todos modos no debemos olvidar que, personalmente no me gustaría que fuera una máquina la que diagnosticara una enfermedad mía y cualquier advenedizo se hiciera cargo del tratamiento de la misma, hay que pensar, que una máquina sigue y seguirá siendo eso, una máquina.